Trials / Conditions / COVID-19 Convalescent Plasma Treatment
COVID-19 Convalescent Plasma Treatment
4 registered clinical trials studyying COVID-19 Convalescent Plasma Treatment.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Covid-19 Convalescent Plasma and Monoclonal Antibodies Treatment of Immunocompromised Patients NCT05905380 | University Hospital, Strasbourg, France | — |
| Unknown | Convalescent Plasma Transfusion in Severe COVID-19 Patients in Jamaica NCT04644198 | The University of The West Indies | Phase 2 |
| Terminated | Application of Convalescent Plasma in the Treatment of SARS CoV-2 Disease (COVID-19) With Evaluation of Therap NCT04642014 | Wroclaw Medical University | N/A |
| Completed | COVID-19 With Convalescent Plasma NCT04616976 | Southeast University, China | — |